- Reckitt Benckiser pursuit of Schiff Nutrition a success; companies sign definitive merger agreement
- Reckitt Benckiser ups the ante for Schiff business with a 23.5% premium to Bayer buyout offer
- Bayer boosts One-A-Day supplement portfolio with Schiff acquisition to the tune of $1.2 billion
- FDA approves Safyral
- Bayer aspirin quick release crystals
NEW YORK — Bayer will not be raising its offer for Schiff Nutrition to match or exceed last week's bid from Reckitt Benckiser, Reuters reported Tuesday morning.
Bayer's bid is still active, however, and is in discussions with Schiff to acquire the company for its original evaluation of $1.2 billion. Reckitt Benckiser bid $1.4 billion.
To read the Reuters report, click here.